• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Revlon

Revlon

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Sunovion Receives Complete Response Letter from FDA for SUN-101/eFlow® (glycopyrrolate) New Drug Application for Chronic Obstructive Pulmonary Disease (COPD)

    Sunovion Receives Complete Response Letter from FDA for SUN-101/eFlow® (glycopyrrolate) New Drug Application for Chronic Obstructive Pulmonary Disease (COPD)

  2. New Analysis of Health Care Law Affirms Increases in Hunger, Poverty

    New Analysis of Health Care Law Affirms Increases in Hunger, Poverty

  3. Trump Budget ‘Robs the Poor to Pay the Rich’

    Trump Budget ‘Robs the Poor to Pay the Rich’

  4. MARKET SNAPSHOT: Stocks In A Battle For Gains After Jobs Data; IBM Drags On Dow

    MARKET SNAPSHOT: Stocks In A Battle For Gains After Jobs Data; IBM Drags On Dow

  5. MARKET SNAPSHOT: Stocks Trade Slightly Higher After Jobs Data As IBM Drags On Dow

    MARKET SNAPSHOT: Stocks Trade Slightly Higher After Jobs Data As IBM Drags On Dow

  6. UPDATE: Stocks trade slightly higher after jobs data as IBM drags on Dow

    UPDATE: Stocks trade slightly higher after jobs data as IBM drags on Dow

  7. MARKET SNAPSHOT: S&P 500, Nasdaq Close At Records After Jobs Data

    MARKET SNAPSHOT: S&P 500, Nasdaq Close At Records After Jobs Data

  8. UPDATE: S&P 500, Nasdaq close at records after jobs data

    UPDATE: S&P 500, Nasdaq close at records after jobs data

  9. UPDATE: Stocks in a battle for gains after jobs data; IBM drags on Dow

    UPDATE: Stocks in a battle for gains after jobs data; IBM drags on Dow

  10. MARKET SNAPSHOT: U.S. Stock Futures Glued In Place As Oil Takes A Roller-coaster Ride; Jobs Data Ahead

    MARKET SNAPSHOT: U.S. Stock Futures Glued In Place As Oil Takes A Roller-coaster Ride; Jobs Data Ahead

12345

©2017 Morningstar Advisor. All right reserved.